智通财经APP获悉，英伟达(NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展(CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。Wedbush分析师Dan ...

随着人工智能应用浪潮席卷而来，Wedbush分析师发表研报表示，看好 甲骨文 (ORCL.US)和Snowflake (SNOW.US)在未来一年的前景。 该行还将Palantir (PLTR.US)和 赛富时 (CRM.US)视为其人工智能软件行业的主要玩家。MongoDB (MDB.US)和Elastic (ESTC.US)也被包括在内，并予以Elastic、MongoDB和Snowflake ...

Wedbush analyst Seth Basham reiterated a Buy rating on Chewy (CHWY – Research Report) today and set a price target of $39.00. The company’s shares opened today at $36.70. Discover ...

Arhaus, Inc. (NASDAQ:ARHS – Free Report) – Investment analysts at Wedbush lifted their FY2024 earnings per share estimates for Arhaus in a research note issued to investors on Friday ...

英伟达 (NVDA.US)首席执行官黄仁勋将于周一在2025年美国消费电子展 (CES)上发表开幕主题演讲。投行Wedbush表示，黄仁勋的演讲可能会聚焦于这家人工智能芯片巨头对人工智能的愿景上。

Wedbush lowered the firm’s price target on Blueprint Medicines (BPMC) to $124 from $135 and keeps an Outperform rating on the shares. The firm notes Blueprint Medicines reported HV data for BLU ...

On Monday, Analysts at Wedbush said a recent tech pullback, triggered by surging Treasury yields and the Federal Reserve's less dovish-eyed view towards 2025, is being viewed as a strategic buying ...

Concerns over the 10-year Treasury yield nearing 5% and a less dovish Federal Reserve outlook for 2025 have spurred risk-off ...

The last item of consequence is the expense ratio. The Vanguard Information Technology ETF has an expense ratio of 0.1%, ...

Wedbush is not changing the firm’s positive bias on Viridian Therapeutics (VRDN) after its competitor Acelyrin (SLRN) hosted an investor event to disclose lonigutamab Phase 2 data and plans for ...

Building on the recent surge in Apple stock, one Wall Street analyst just lifted his price target to a Street-high level of ...

Investing.com -- WingStop has been added to the Wedbush Best Ideas List, with the firm forecasting strong growth potential for the company in 2025. According to Wedbush analysts, WingStop is ...